HORMONAL-REGULATION OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES

被引:160
作者
CONTI, M
JIN, SLC
MONACO, L
REPASKE, DR
SWINNEN, JV
机构
[1] UNIV N CAROLINA, DEPT PEDIAT,REPROD BIOL LAB,CB 7500,MACNIDER 202H, CHAPEL HILL, NC 27599 USA
[2] UNIV N CAROLINA, DEPT PHYSIOL, CHAPEL HILL, NC 27599 USA
[3] UNIV ROME, INST HISTOL & GEN EMBRYOL, I-00100 ROME, ITALY
关键词
D O I
10.1210/edrv-12-3-218
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Acomplex array of signals from the extracellular environment regulate many cell processes, including the entry and exit from the mitotic cycle and the induction and maintenance of differentiation (1–3). Cells elaborate these external stimuli via receptors, transducers, and second messengers (4, 5) which control intricate circuits that lead to protein phosphorylation by protein kinases (6, 7). Although novel second messenger pathways have been discovered and dissected in some detail in the past 10 years (8, 9), cyclic nucleotides (cAMP and cGMP) remain the best characterized second messengers, and their role in the differentiation and control of metabolic processes of the endocrine cell is widely recognized. The components of the membrane-associated machinery that transduces external signals into changes in cyclic nucleotide levels have been isolated and characterized. These include many members of the family of membrane receptors (10–14), G proteins acting as transducers (15, 16), and adenylate cyclase effectors (15, 17). Furthermore, complementary DNAs that encode these components are becoming available (10–17), thus opening new avenues by which to study the structure and function of these membrane-associated, protein complexes. © 1991 by The Endocrine Society.
引用
收藏
页码:218 / 234
页数:17
相关论文
共 188 条
[1]  
ABUMRAD NA, 1988, J BIOL CHEM, V263, P14678
[2]  
ABUMRAD NA, 1986, J BIOL CHEM, V261, P2999
[3]   A SPATIAL-TEMPORAL MODEL OF CELL ACTIVATION [J].
ALKON, DL ;
RASMUSSEN, H .
SCIENCE, 1988, 239 (4843) :998-1005
[4]   CHARACTERIZATION OF SEVERAL CLONAL LINES OF CULTURED LEYDIG TUMOR-CELLS - GONADOTROPIN RECEPTORS AND STEROIDOGENIC RESPONSES [J].
ASCOLI, M .
ENDOCRINOLOGY, 1981, 108 (01) :88-95
[5]  
ASHBY B, 1989, MOL PHARMACOL, V36, P866
[6]  
BARBER R, 1980, J CYCLIC NUCL PROT, V6, P3
[7]  
Barber R, 1978, Adv Cyclic Nucleotide Res, V9, P507
[8]  
BARBER R, 1981, MOL PHARMACOL, V19, P38
[9]  
BEAVO JA, 1988, ADV SEC MESS PHOSPH, V22, P1
[10]   PRIMARY SEQUENCE OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ISOZYMES AND THE DESIGN OF SELECTIVE INHIBITORS [J].
BEAVO, JA ;
REIFSNYDER, DH .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (04) :150-155